Display Options:
Total: 968
Antibody
Investigational
Unknown
Unknown
Purpura, Thrombocytopenic, Idiopathic
Complement C1s inhibitor
Antibody
Investigational
Unknown
Unknown
Neuroblastoma; Carcinoma, Non-Small-Cell Lung
Ganglioside GM3 (NeuGcGM3) inhibitor
Antibody
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
CD22 binding agent
Antibody
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung
Unknown
Antibody
Investigational
Unknown
Unknown
Frontotemporal Dementia
Unknown
Antibody
Investigational
Unknown
Unknown
Neuroblastoma; Carcinoma; Ovarian Neoplasms; Rectal Neoplasms; Adenocarcinoma, Clear Cell; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colorectal Neoplasms; Endometrial Neoplasms; Granuloma, Lethal Midline; Immunoblastic Lymphadenopathy; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Mouth Neoplasms; Neoplasms; Sarcoma; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Hodgkin Disease; Lung Neoplasms; Nasopharyngeal Neoplasms; Stomach Neoplasms
Programmed cell death protein 1 antagonist
Antibody
Investigational
Unknown
Unknown
Multiple Myeloma; Multiple Sclerosis, Relapsing-Remitting; Renal Insufficiency, Chronic; Arthritis, Rheumatoid; Lupus Erythematosus, Systemic
Tumor necrosis factor ligand superfamily member 13B inhibitor
Antibody
Investigational
Unknown
Unknown
Scleroderma, Localized; Arthritis, Rheumatoid; Lupus Nephritis; Lupus Erythematosus, Systemic
Interferon-alpha/beta receptor alpha chain antagonist
Antibody
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms; Primary Myelofibrosis; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes
Hepatitis A virus cellular receptor 2 inhibitor
Antibody
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Mucin-1 binding agent
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
Antibody
Investigational
Unknown
Unknown
Hernias, Diaphragmatic, Congenital; Respiratory Sounds; Respiratory Syncytial Virus Infections
Fusion glycoprotein F0 inhibitor
Antibody
Investigational
Unknown
Unknown
Glomerulonephritis, Membranous; Glomerulonephritis; Kidney Diseases; Multiple Myeloma
Lymphocyte differentiation antigen CD38 inhibitor
Antibody
Investigational
Unknown
Unknown
Epstein-Barr Virus Infections; Colonic Neoplasms; Liposarcoma; Mouth Neoplasms; Thrombosis; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colorectal Neoplasms; Granuloma, Lethal Midline; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Hypopharyngeal Neoplasms; Mesothelioma; Neoplasms; Salivary Gland Neoplasms; Sarcoma; Stomach Neoplasms; Thyroid Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Lymphoma; Melanoma; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms
Programmed cell death protein 1 antagonist
Antibody
Investigational
Unknown
Unknown
Hodgkin Disease; Burkitt Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Mantle-Cell; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin
B-lymphocyte antigen CD20 binding agent
Antibody
Investigational
Unknown
Unknown
Carcinoma, Squamous Cell; Neoplasms; Breast Neoplasms; Head and Neck Neoplasms; Hemangiosarcoma; Carcinoma, Non-Small-Cell Lung
Receptor tyrosine-protein kinase erbB-3 inhibitor
Antibody
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Lymphoma
T-lymphocyte activation antigen CD80 inhibitor
Antibody
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Glioma; Gliosarcoma; Mesothelioma; Stomach Neoplasms
Hepatocyte growth factor inhibitor
Antibody
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms
Mucin-16 other
Antibody
Investigational
Unknown
Unknown
Genital Neoplasms, Female; Head and Neck Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Squamous Cell Carcinoma of Head and Neck; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Severe Acute Respiratory Syndrome; Carcinoma, Squamous Cell
NKG2-A/NKG2-B type II integral membrane protein inhibitor
Antibody
Investigational
Unknown
Unknown
Carcinoma, Renal Cell
Carbonic anhydrase IX binding agent
Antibody
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
CD22 binding agent
Antibody
Investigational
Unknown
Unknown
Cachexia; Diabetes Mellitus, Type 2; Muscular Atrophy; Pulmonary Disease, Chronic Obstructive; Sarcopenia; Myositis, Inclusion Body
Activin receptor type-2B antagonist
Antibody
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections
Fusion glycoprotein F0 inhibitor
Antibody
Investigational
Unknown
Unknown
Macular Degeneration; Wet Macular Degeneration
Angiopoietin-2 inhibitor
Antibody
Investigational
Unknown
Unknown
Leukemia, Myelomonocytic, Chronic; Multiple Myeloma; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Leukemia
Myeloid cell surface antigen CD33 other
Antibody
Investigational
Unknown
Unknown
Lupus Nephritis; Severe Acute Respiratory Syndrome; Atypical Hemolytic Uremic Syndrome; Glomerulonephritis, IGA
Mannan-binding lectin serine protease 2 inhibitor
Antibody
Investigational
Unknown
Unknown
Idiopathic Pulmonary Fibrosis; Pulmonary Disease, Chronic Obstructive; Asthma; Dermatitis, Atopic
Interleukin-13 inhibitor
Antibody
Investigational
Unknown
Unknown
Unknown
Urushiol inhibitor
Antibody
Investigational
Unknown
Unknown
Lymphoma; Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Hepatocellular; Esophageal Neoplasms; Thymoma; Carcinoma, Non-Small-Cell Lung
Cytotoxic T-lymphocyte protein 4 inhibitor
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Melanoma; Carcinoma, Merkel Cell; Endometrial Neoplasms; Esophageal Neoplasms; Glioblastoma; Malignant Carcinoid Syndrome; Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Sarcoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell
Programmed cell death protein 1 antagonist
Antibody
Investigational
Unknown
Unknown
Unknown
Lipopolysaccharide (LPS) other
Antibody
Investigational
Unknown
Unknown
Neoplasms; Adenocarcinoma; Brain Stem Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Glioma; Hypopharyngeal Neoplasms; Lung Neoplasms; Oropharyngeal Neoplasms; Penile Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Diffuse Intrinsic Pontine Glioma; Esophageal Neoplasms; Glioblastoma; Head and Neck Neoplasms; Nasopharyngeal Neoplasms; Pancreatic Neoplasms; Uterine Cervical Neoplasms
Epidermal growth factor receptor erbB1 inhibitor